FDA ingredient review activity accelerated, energy-driven costs rose again, and AI discussions moved beyond experimentation toward operational integration.
Read MoreNewsletter
FDA ingredient review activity accelerated, energy-driven costs rose again, and AI discussions moved beyond experimentation toward operational integration.
Read MoreNewsletter